Allspring Global Investments Holdings, LLC Denali Therapeutics Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 5,676 shares of DNLI stock, worth $155,919. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,676
Previous 6,097
6.91%
Holding current value
$155,919
Previous $141,000
17.02%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DNLI
# of Institutions
216Shares Held
115MCall Options Held
127KPut Options Held
38.3K-
Baillie Gifford & CO13.8MShares$378 Million0.25% of portfolio
-
Black Rock Inc. New York, NY13.2MShares$362 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$311 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA9.82MShares$270 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.13MShares$196 Million0.04% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $3.69B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...